Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Authors
Keywords
Parallel reaction monitoring, Synaptic proteins, CSF biomarkers, Alzheimer’s disease
Journal
Alzheimers Research & Therapy
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-15
DOI
10.1186/s13195-017-0335-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice
- (2017) Jordano Brito-Moreira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals
- (2017) Aaron P. Schultz et al. JOURNAL OF NEUROSCIENCE
- A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease
- (2017) Gunnar Brinkmalm et al. Proteomics Clinical Applications
- Reduced Levels of Amyloid-β-Binding Proteins in Cerebrospinal Fluid from Alzheimer's Disease Patients
- (2017) Sara F. Hansson et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- β-amyloid increases neurocan expression through regulating Sox9 in astrocytes: A potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease
- (2016) Han Yan et al. BRAIN RESEARCH
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics—Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
- (2014) Mikko Hölttä et al. JOURNAL OF PROTEOME RESEARCH
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity
- (2013) C. R. Jack et al. NEUROLOGY
- CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
- (2013) N Mattsson et al. Translational Psychiatry
- Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study
- (2012) Wesley Jongbloed et al. Alzheimers & Dementia
- Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease
- (2012) Anne M Fagan et al. Biomarkers in Medicine
- Neurofascin: A switch between neuronal plasticity and stability
- (2012) Martin Kriebel et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeted proteome investigation via selected reaction monitoring mass spectrometry
- (2012) Alessio Maiolica et al. Journal of Proteomics
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- The Extended Granin Family: Structure, Function, and Biomedical Implications
- (2011) Alessandro Bartolomucci et al. ENDOCRINE REVIEWS
- Chromogranin peptides in brain diseases
- (2011) Michael Willis et al. JOURNAL OF NEURAL TRANSMISSION
- A Critical Role for Neurofascin in Regulating Action Potential Initiation through Maintenance of the Axon Initial Segment
- (2011) Barbara Zonta et al. NEURON
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
- (2011) Holger Jahn et al. PLoS One
- Lysozymes in the animal kingdom
- (2010) Lien Callewaert et al. JOURNAL OF BIOSCIENCES
- Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
- (2010) A.C. Kroksveen et al. Journal of Proteomics
- Clinical proteomics in neurodegenerative disorders
- (2008) H. Zetterberg et al. ACTA NEUROLOGICA SCANDINAVICA
- The Neurotrophin-Inducible Gene Vgf Regulates Hippocampal Function and Behavior through a Brain-Derived Neurotrophic Factor-Dependent Mechanism
- (2008) O. Bozdagi et al. JOURNAL OF NEUROSCIENCE
- Cystatin C-Cathepsin B Axis Regulates Amyloid Beta Levels and Associated Neuronal Deficits in an Animal Model of Alzheimer's Disease
- (2008) Binggui Sun et al. NEURON
- Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
- (2007) A.H. Simonsen et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation